First Trust Advisors
TNGX icon

First Trust Advisors’s Tango Therapeutics TNGX Stock Holding History

First Trust Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
+509,309
New +$12.6M 0.01% 1016
2024
Q4 		– Sell
-384,500
Closed -$2.96M – 2642
2024
Q3 		$2.96M Buy
384,500
+334,747
+673% +$3.19M ﹤0.01% 1593
2024
Q2 		$427K Buy
+49,753
New +$384K ﹤0.01% 2158

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

First Trust Advisors's TNGX Position: Q2 2026 in Review

First Trust Advisors opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 509,309 shares worth $15.9M. The stake represents 0.01% of the portfolio and ranks #1016 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in TNGX as recently as Q3 2024.

First Trust Advisors first reported a position in TNGX in Q2 2024 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • First Trust Advisors held 509,309 shares of Tango Therapeutics worth $15.9M as of Q2 2026.
  • Tango Therapeutics was a new First Trust Advisors position in Q2 2026.
  • Tango Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1016 holding.
  • First Trust Advisors first reported a position in Tango Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.